Mixed Connective Tissue Disease (MCTD)
What is Mixed Connective Tissue Disease (MCTD)?
Mixed Connective Tissue Disease (MCTD) is a rare autoimmune condition that shows overlapping features of multiple connective tissue diseases, primarily lupus, scleroderma, and polymyositis. The immune system becomes overactive and mistakenly attacks healthy tissues, leading to symptoms such as fatigue, joint pain, muscle weakness, swollen fingers, Raynaud’s phenomenon, and sometimes involvement of the lungs, heart, or esophagus. Because symptoms vary widely from person to person, early diagnosis and specialised care are essential.
How MCTD is Treated
Treatment focuses on controlling inflammation, managing symptoms, and preventing organ involvement. Management usually includes:
- Anti-inflammatory medications to manage pain and swelling
- Corticosteroids for controlling active inflammation or flare-ups
- Immunosuppressive medications to regulate the immune response
- Drugs for Raynaud’s phenomenon to improve blood flow
- Physiotherapy to maintain muscle strength and joint mobility
- Regular monitoring, especially for lung and heart-related complications
With timely treatment and ongoing follow-up, many individuals with MCTD can maintain good long-term control and improved quality of life.
If you are experiencing persistent fatigue, joint pain, or symptoms that suggest an autoimmune overlap condition, you may book a consultation with Dr. Harsh Jain for Mixed Connective Tissue Disease Treatment in Mumbai. Please visit our website or contact us on the numbers provided.